Is a
Funding Round attributes
Funding Type
Funded Company
Funding Round Amount (USD)
90,000,000
Announcement URL
Funding Round Date
September 3, 2024
Other attributes
Phone Number
+16176204606
Circle Pharma, a clinical-stage biopharmaceutical company, has raised $90 million in a Series D funding round. The financing was led by The Column Group, with additional support from Nextech Invest, Euclidean Capital, and other existing investors. This round also included the conversion of a convertible note. The company is focused on developing cell-permeable macrocycles, a new class of therapies, with an emphasis on targeting cyclins, which play a critical role in the progression of cancer. Circle Pharma’s MXMO™ platform drives its research in this area.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
